Additionally, our analysis found no significant difference in the occurrence of postoperative acute respiratory failure between patients who were receiving GLP-1 RAs and those who were not, suggesting that the use of GLP-1 RAs is not associated with an increased risk of additional adverse respiratory events following surgery. The gene discussed is GLP1R; the disease is acute respiratory failure.